Literature DB >> 1064430

Response of remission lymphocytes to autochthonous leukaemic myeloblasts.

G M Taylor, C B Freeman, R Harris.   

Abstract

Thymidine incorporation in vitro by remission lymphocytes from a total of 6 patients with acute myeloid leukaemia (AML) was measured following stimulation by autochthonous and allogeneic AML blasts and cell lines. The early peak response to autochthonous blasts in 2 of these patients (48-72 h) is consistent with the concept of a population of lymphocytes pre-immunized to antigens carried by the blasts. Although stimulation in one patient was increased in the presence of more stimulating (S) blasts than responding (R) lymphocytes, positive responses in other tests were obtained at an S : R ratio of 1 : 1-5. When different methods of treatment of the stimulating autochthonous blasts were compared with untreated cells, mitomycin C gave the highest stimulation indices 2 out of 3 tests. Tissue culture medium in which autochthonous blasts had been incubated for 3-5 days failed to stimulate either remission lymphocytes alone, or combined cultures of lymphocytes with autochthonous or allogeneic blasts, suggesting that mitogenic factors released from autochthonous blasts are not responsible for lymphocyte stimulation. Treatment of autochthonous or allogeneic AML blasts with glycine-HC1(pH 3-0) to remove putative "blocking" factors failed to increase the stimulatory capacity of the leukaemic blasts.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1064430      PMCID: PMC2024968          DOI: 10.1038/bjc.1976.81

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  26 in total

1.  Auto-immunization with acute leukemia cells: demonstration of increased lymphocyte responsiveness.

Authors:  J U Gutterman; G Mavligit; K B McCredie; E J Freireich; E M Hersh
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

2.  Cutaneous delayed hypersensitivity responses to tumor-associated and other antigens in acute leukemia.

Authors:  D H Char; B G Lepourhiet; R B Herberman
Journal:  Int J Cancer       Date:  1973-09-15       Impact factor: 7.396

3.  In vitro lymphocyte response to autologous cultured lymphoid cells.

Authors:  T Han; G E Moore; J E Sokal
Journal:  Proc Soc Exp Biol Med       Date:  1971-03

4.  Stimulation of lymphocytes by autologous leukaemic cells in acute leukaemia.

Authors:  W H Fridman; F M Kourilsky
Journal:  Nature       Date:  1969-10-18       Impact factor: 49.962

Review 5.  Immunochemotherapy of human cancer.

Authors:  J U Gutterman; G M Mavligit; R C Reed; E M Hersh
Journal:  Semin Oncol       Date:  1974-12       Impact factor: 4.929

6.  Antigen solubilized from human leukemia: lymphocyte stimulation.

Authors:  J U Gutterman; G Mavligit; K B McCredie; G P Bodey; E J Freireich; E M Hersh
Journal:  Science       Date:  1972-09-22       Impact factor: 47.728

7.  Active immunotherapy used alone for maintenance of patients with acute myeloid leukaemia.

Authors:  C B Freeman; R Harris; C G Geary; M J Leyland; J E MaCiver; I W Delamore
Journal:  Br Med J       Date:  1973-12-08

8.  Recognition of leukaemia cells as foreign before and after autoimmunization.

Authors:  R L Powles; L A Balchin; G H Fairley; P Alexander
Journal:  Br Med J       Date:  1971-02-27

9.  Lymphocyte transformation induced by autologous cells. II. Stimulation by mitogen-induced lymphoblasts.

Authors:  M E Weksler
Journal:  J Exp Med       Date:  1973-03-01       Impact factor: 14.307

10.  Immunological studies in acute myeloid leukaemia: PHA responsiveness and serum inhibitory factors.

Authors:  J S Walker; D Davis; P Davies; C B Freeman; R Harris
Journal:  Br J Cancer       Date:  1973-03       Impact factor: 7.640

View more
  4 in total

1.  Suppression of lymphoproliferative responses to alloantigens by autologous AML cells.

Authors:  G M Taylor; W D Fergusson; R Harris
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

2.  Stimulation of human lymphocytes in vitro by leucocytes from patients with untreated acute myeloid leukaemia.

Authors:  G M Taylor; S V Jones; J C Ridway; R Harris
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

3.  Surface antigens in acute myeloblastic leukaemia: a study using heterologous antisera.

Authors:  L Tupchong; I C MacLennan
Journal:  Br J Cancer       Date:  1978-10       Impact factor: 7.640

4.  Lack of correlation between lymphocyte activating determinants and HLA-DR on acute leukaemias.

Authors:  G M Taylor; J C Ridway; W D Fergusson; R Harris
Journal:  Br J Cancer       Date:  1984-04       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.